Mufg Securities Americas Inc. Buys 2,292 Shares of UnitedHealth Group Incorporated $UNH

Posted by Francis Steltz on Aug 29th, 2026

Mufg Securities Americas Inc. grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 9.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 27,352 shares of the healthcare conglomerate’s stock after acquiring an additional 2,292 shares during the quarter. Mufg Securities Americas Inc.’s holdings in UnitedHealth Group were worth $11,368,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently made changes to their positions in the company. Nissay Asset Management Corp Japan boosted its holdings in UnitedHealth Group by 2.3% during the second quarter. Nissay Asset Management Corp Japan now owns 120,615 shares of the healthcare conglomerate’s stock worth $50,131,000 after purchasing an additional 2,678 shares during the last quarter. Campbell Newman Asset Management Inc. bought a new position in shares of UnitedHealth Group during the 2nd quarter worth approximately $45,411,000. Field & Main Bank bought a new position in shares of UnitedHealth Group in the second quarter valued at approximately $3,926,000. Wellington Management Group LLP increased its position in shares of UnitedHealth Group by 5.8% during the second quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate’s stock valued at $4,436,923,000 after acquiring an additional 583,536 shares during the last quarter. Finally, Tilia Fiduciary Partners Inc. boosted its position in UnitedHealth Group by 4.1% in the second quarter. Tilia Fiduciary Partners Inc. now owns 7,020 shares of the healthcare conglomerate’s stock worth $2,918,000 after purchasing an additional 276 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $393.99 on Friday. The firm has a market capitalization of $353.64 billion, a PE ratio of 25.35, a P/E/G ratio of 1.36 and a beta of 0.62. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. The company has a 50-day moving average price of $413.28 and a two-hundred day moving average price of $360.11. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62.

UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, beating analysts’ consensus estimates of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The company had revenue of $112.03 billion for the quarter, compared to analysts’ expectations of $110.81 billion. During the same period in the prior year, the company posted $4.08 EPS. UnitedHealth Group’s revenue was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 19.82 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be given a $2.32 dividend. The ex-dividend date is Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. UnitedHealth Group’s payout ratio is 59.72%.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 1,169 shares of the stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This represents a 7.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.19% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of recent analyst reports. Sanford C. Bernstein reiterated an “outperform” rating on shares of UnitedHealth Group in a research note on Tuesday, July 21st. KeyCorp raised their price objective on shares of UnitedHealth Group from $400.00 to $475.00 and gave the stock an “overweight” rating in a report on Tuesday, July 14th. Weiss Ratings downgraded shares of UnitedHealth Group from a “hold (c)” rating to a “hold (c-)” rating in a research report on Tuesday, July 28th. Piper Sandler set a $477.00 price target on shares of UnitedHealth Group in a report on Thursday, July 16th. Finally, BMO Capital Markets set a $512.00 price objective on UnitedHealth Group in a report on Tuesday, July 21st. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $456.56.

Check Out Our Latest Report on UnitedHealth Group

About UnitedHealth Group

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.